Last10K.com

Wize Pharma, Inc. (WIZP) SEC Filing 8-K Material Event for the period ending Wednesday, October 24, 2018

Wize Pharma, Inc.

CIK: 1218683 Ticker: WIZP

View differences made from one to another to evaluate Wize Pharma, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Wize Pharma, Inc..

Continue

Assess how Wize Pharma, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Wize Pharma, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Wize Pharma, Inc. provided additional information to their SEC Filing as exhibits

Ticker: WIZP
CIK: 1218683
Form Type: 8-K Corporate News
Accession Number: 0001213900-18-014440
Submitted to the SEC: Thu Oct 25 2018 8:20:23 AM EST
Accepted by the SEC: Thu Oct 25 2018
Period: Wednesday, October 24, 2018
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/wizp/0001213900-18-014440.htm